Fresh from a £4m investment drive in new production capabilities and clean room capacity, Essex-based Europlaz has reinforced its compliance with the regulatory requirements expected by the FDA – United States Food and Drug Administration.
This means the company can build on more than £1.5m of sales into this important territory, with the family-run business now setting its sights on more than doubling this figure over the next two years.
Alastair Fry
“A successful FDA inspection demonstrates that our systems, facility, and processes meet the highest standards,” explained Alastair Fry, Regulatory Affairs Manager at Europlaz.
“It provides external validation that we operate with the same level of rigour expected of US-based manufacturers, giving existing and potential customers complete confidence in the quality and safety of the products we produce for them.”
He continued: “For medical devices sold in the US market, compliance to the FDA’s Code of Federal Regulations is not optional – it is a regulatory requirement. A successful inspection confirms that we can fully support customers in bringing their devices to the United States.”
The three-day inspection involved a comprehensive review of Europlaz’s quality management system, manufacturing processes, documentation and production facility.
Alastair went on to add: “Compliance to the FDA’s Code of Federal Regulations ensures that quality is never compromised and that safety is built into every step of our production, whether its producing finished devices or components.”
Operating from its state-of-the-art site in Southminster, near Chelmsford, Europlaz’s main focus is on helping medical device and healthcare businesses commercialise new technology.
From here, the family-run business has invested £4m into creating a world class facility capable of injection moulding, assembly, product validation and access to modern cleanrooms (all ISO Class 7) for the manufacture of Class I and Class II medical devices.
Rory O’Keeffe, Commercial Director of Europlaz, concluded: “The successful inspection is recognition of the hard work and commitment of our team, so a massive thank you to them. And to the wider industry, we want to signal that we are ready to support the global innovation, compliance, and growth in healthcare and medical devices.”
For further information, please visit www.europlaz.co.uk
More medical stories can be found here: https://designsolutionsmag.co.uk/category/medical/
